RANUNCULUS BULBOSUS (Rxhomeo Private Limited d.b.a. Rxhomeo, Inc)


Welcome to the PulseAid listing for the RANUNCULUS BULBOSUS drug offered from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
NON-PROPRIETARY NAME: RANUNCULUS BULBOSUS
SUBSTANCE NAME: RANUNCULUS BULBOSUS
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-11-05
END MARKETING DATE: 0000-00-00


RANUNCULUS BULBOSUS HUMAN OTC DRUG Details:

Item DescriptionRANUNCULUS BULBOSUS from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
LABELER NAME: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 3([hp_X]/1)
START MARKETING DATE: 2015-11-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 15631-0364_7fec3785-2481-44b4-ba85-d533bb9f3746
PRODUCT NDC: 15631-0364
APPLICATION NUMBER:

Other RANUNCULUS BULBOSUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Laboratoires BoironRanunculus bulbosus
Paramesh Banerji Life Sciences LLCRanunculus bulbosus 30C
Rxhomeo Private Limited d.b.a. Rxhomeo, IncRANUNCULUS BULBOSUS
Washington Homeopathic ProductsRanunculus Bulbosus